Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Get Free Report) was the target of a large decrease in short interest during the month of November. As of November 30th, there was short interest totalling 108,400 shares, a decrease of 41.4% from the November 15th total of 185,000 shares. Currently, 1.7% of the company’s stock are short sold. Based on an average trading volume of 113,400 shares, the short-interest ratio is currently 1.0 days.
Insider Activity
In other news, CEO Vininder Singh sold 14,405 shares of the business’s stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $2.65, for a total value of $38,173.25. Following the completion of the sale, the chief executive officer now directly owns 2,478,041 shares in the company, valued at approximately $6,566,808.65. The trade was a 0.58 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In the last quarter, insiders have sold 31,603 shares of company stock valued at $82,989. Insiders own 33.90% of the company’s stock.
Hedge Funds Weigh In On Bullfrog AI
An institutional investor recently bought a new position in Bullfrog AI stock. Renaissance Technologies LLC acquired a new stake in Bullfrog AI Holdings, Inc. (NASDAQ:BFRG – Free Report) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 19,800 shares of the company’s stock, valued at approximately $34,000. Renaissance Technologies LLC owned 0.25% of Bullfrog AI at the end of the most recent quarter. Hedge funds and other institutional investors own 0.96% of the company’s stock.
Bullfrog AI Trading Down 3.1 %
Bullfrog AI Company Profile
Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.
See Also
- Five stocks we like better than Bullfrog AI
- Low PE Growth Stocks: Unlocking Investment Opportunities
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Stock Average Calculator
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- Top Biotech Stocks: Exploring Innovation Opportunities
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Bullfrog AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bullfrog AI and related companies with MarketBeat.com's FREE daily email newsletter.